Ahmad Awada

25.1k total citations · 4 hit papers
542 papers, 16.2k citations indexed

About

Ahmad Awada is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ahmad Awada has authored 542 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 393 papers in Oncology, 195 papers in Pulmonary and Respiratory Medicine and 139 papers in Molecular Biology. Recurrent topics in Ahmad Awada's work include Cancer Treatment and Pharmacology (162 papers), HER2/EGFR in Cancer Research (114 papers) and Advanced Breast Cancer Therapies (76 papers). Ahmad Awada is often cited by papers focused on Cancer Treatment and Pharmacology (162 papers), HER2/EGFR in Cancer Research (114 papers) and Advanced Breast Cancer Therapies (76 papers). Ahmad Awada collaborates with scholars based in Belgium, United States and France. Ahmad Awada's co-authors include Martine Piccart, Brian Schwartz, Evandro de Azambuja, Javier Cortés, Dirk Strumberg, Gilberto de Castro, Philippe Aftimos, Alain Hendlisz, Thierry Gil and Jan B. Vermorken and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ahmad Awada

527 papers receiving 15.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

2007 1.2k citations Ahmad Awada et al. profile →
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

2004 694 citations Ahmad Awada et al. Journal of Clinical Oncology profile →
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

2019 407 citations Angelo Di Leo, Seock‐Ah Im et al. npj Breast Cancer profile →
Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

2018 348 citations Denise A. Yardley, Joyce O’Shaughnessy et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ahmad Awada

Since Specialization

Citations

This map shows the geographic impact of Ahmad Awada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Awada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Awada more than expected).

Fields of papers citing papers by Ahmad Awada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Awada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Awada. The network helps show where Ahmad Awada may publish in the future.

Co-authorship network of co-authors of Ahmad Awada

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Awada. A scholar is included among the top collaborators of Ahmad Awada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Awada. Ahmad Awada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer 2024 ·Cancers ·(unknown), Soizic Garaud, (unknown), (unknown), Anaïs Boisson, Alexandre de Wind, (unknown), Ligia Craciun, (unknown), Ahmad Awada, Karen Willard‐Gallo	2
2	Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer 2024 ·Current Oncology ·Ahmad Awada, Sarfraz Ahmad	1
3	Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies 2023 ·Cells ·Ahmad Najem, Mohammad Krayem, (unknown), (unknown), Fabrice Journé, Ahmad Awada, Laurent Désaubry, Ghanem E. Ghanem	5
4	PIK3CAcopy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer 2023 ·Molecular Case Studies ·Ottavia Amato, Laurence Buisseret, Géraldine Gebhart, (unknown), Denis Larsimont, Ahmad Awada, Martine Piccart, Philippe Aftimos	5
5	Challenges and knowledge gaps with immune checkpoint inhibitors monotherapy in the management of patients with non-small-cell lung cancer: a survey of oncologist perceptions 2023 ·ESMO Open ·Luís Castelo-Branco, Gilberto Morgan, Arsela Prelaj, Matthias Scheffler, Helena Canhão, Jan P. van Meerbeeck, Ahmad Awada	7
6	Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours 2023 ·European Journal of Cancer ·Patrick Schöffski, Jean‐Pascal Machiels, Sylvie Rottey, (unknown), Hanny Musa, Kristell Marzin, Ahmad Awada	10
7	On the Analysis and Optimization of Fast Conditional Handover With Hand Blockage for Mobility 2023 ·IEEE Access ·(unknown), (unknown), Ahmad Awada, (unknown), Philipp Schulz, Gerhard Fettweis	11
8	Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse 2022 ·JCO Precision Oncology ·(unknown), Elisa Agostinetto, Matteo Lambertini, Françoise Rothé, Hsin-Ta Wu, Mustafa Balcioglu, Ekaterina Kalashnikova, Delphine Vincent, (unknown), Andrea Gombos, (unknown), Isabelle Veys, Ahmad Awada, Himanshu Sethi, Alexey Aleshin, Denis Larsimont, Christos Sotiriou, David Venet, Michail Ignatiadis	48
9	Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study 2022 ·Clinical Cancer Research ·Vivek Subbiah, Irene Braña, Alessandra Longhi, Valentina Boni, Jean‐Pierre Delord, Ahmad Awada, Pascaline Boudou‐Rouquette, John Sarantopoulos, Geoffrey I. Shapiro, Anthony Elias, Ravin Ratan, Cristian Fernández, Carmen Kahatt, Martín Cullell-Young, Mariano Siguero, Ali Zeaiter, Sant P. Chawla	18
10	Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis 2022 ·Journal of Cancer Research and Clinical Oncology ·Diogo Martins-Branco, Guilherme Nader Marta, (unknown), Véronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Angela Loizidou, Karen Willard‐Gallo, (unknown), Ahmad Awada, Martine Piccart, Evandro de Azambuja	9
11	Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit 2021 ·Molecular Cancer Research ·(unknown), Mohammad Krayem, Ahmad Najem, François Salès, Wilson H. Miller, Sonia V. del Rincón, Ahmad Awada, (unknown), Fabrice Journé	4
12	FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer 2021 ·npj Breast Cancer ·Andrea Gombos, David Venet, Lieveke Ameye, Peter Vuylsteke, Patrick Neven, Vincent R. Richard, François P. Duhoux, Jean‐François Laes, Françoise Rothé, Christos Sotiriou, Marianne Paesmans, Ahmad Awada, Thomas Guiot, Patrick Flamen, Martine Piccart, Michail Ignatiadis, Géraldine Gebhart	14
13	A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer 2020 ·Clinical Cancer Research ·Sara M. Tolaney, Solmaz Sahebjam, Émilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise A. Yardley, Arlene Chan, Pierfranco Conté, Véronique Dièras, Nancy U. Lin, (unknown), Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders	144
14	Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol 2018 ·Clinical Cancer Research ·Hope S. Rugo, Javier Cortés, Ahmad Awada, Joyce O’Shaughnessy, Chris Twelves, Seock‐Ah Im, Alison L. Hannah, Lin Lü, Sherwin K. B. Sy, (unknown), Deborah A. Zajchowski, Darren W. Davis, Mary Tagliaferri, Ute Hoch, Edith A. Perez	17
15	Retroperitoneal mixed malignant mullerian tumor : exceptional localisation and prognosis 2018 ·PubMed ·(unknown), Christiane Jungels, Denis Larsimont, Ahmad Awada	1
16	Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies 2017 ·Clinical Cancer Research ·Philippe Aftimos, Christian Rolfo, Sylvie Rottey, Fritz Offner, Dominique Bron, Marie Maerevoet, Jean‐Charles Soria, Mahan Moshir, Torsten Dreier, Luc Van Rompaey, Jean‐Marie Michot, Karen Silence, Anna Hultberg, Domenica Gandini, Hans de Haard, Vincent Ribrag, Marc Peeters, Alain Thibault, Nicolas Leupin, Ahmad Awada	47
17	A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study) 2014 ·The Breast ·P. Fumoleau, Kevin M. Koch, Étienne Brain, François Lokiec, Keyvan Rezaï, Ahmad Awada, Larry Hayward, Gustavo Werutsky, Jan Bogaerts, Sandrine Marréaud, Fátima Cardoso	10
18	Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer 2013 ·Journal of Clinical Oncology ·José Baselga, Patricia Gómez, Richard Greil, Sofía Braga, Miguel Ángel Climent, Andrew Wardley, Bella Kaufman, Salomon M. Stemmer, António Pêgo, Arlene Chan, J. Goeminne, Marie-Pascale Graas, Megan Kennedy, Eva María Ciruelos Gil, Andreas Schneeweiß, Angela Zubel, Jutta Groos, Helena Melezínková, Ahmad Awada	298
19	Abstracts 2003 ·British Journal of Cancer ·Ahmad Awada, Jean Klášterský, (unknown), Christian Stoll, (unknown), (unknown), S. Korfee, Gerald Antoch, Thomas Gauler, Wilfried Eberhardt, Anna Kowalczyk, Rafał Dziadziuszko, Ewa Szutowicz-Zielińska, A. Badzio, Jacek Jassem	1
20	Actualités thérapeutiques dans le cancer du sein 2000 ·Bulletin du Cancer ·Ahmad Awada, Angelo Di Leo, Martine Piccart	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact